BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
根据最新的财务报表(Form-10K),BGM Group Ltd 的总资产为 $53,净损失为 $-1
BGM 的关键财务比率是什么?
BGM Group Ltd 的流动比率是 5.3,净利 margin 为 -4,每股销售为 $3.45。
BGM Group Ltd 的收入按细分市场或地理位置如何划分?
BGM Group Ltd 最大收入来源是 Oxytetracycline & Licorice Products and Traditional Chinese Medicine Derivatives,在最近的收益报告中收入为 21,961,282。就地区而言, China 是 BGM Group Ltd 的主要市场,收入为 25,097,951。